fda statement bpc 157 not approved for human use 🙋🏻‍♂️ Is the lack of data in BPC-157 a red flag? • If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury FDA's Overreach on Compounded Peptides

Learn more about collagen supplements, including evidence from clinical studies on arthritis and muscle strength and safety

A pentadecapeptide, BPC-157 is derived from Body Protection Compound (BPC), an endogenous gastric protein that is produced in the human digestive tract

Standard clinical dose escalation The FDA-approved Mounjaro (brand tirzepatide) follows this schedule: Weeks 1-4: 2.5 mg once weekly (starting dose, allows GI adaptation) Weeks 5-8: 5 mg once weekly (first therapeutic dose increase) Weeks 9-12: 7.5 mg once weekly (if tolerated and additional effect needed) Weeks 13-16: 10 mg once weekly (continued escalation) Weeks 17-20: 12.5 mg once weekly (approaching maximum) Week 21+: 15 mg once weekly (maximum approved dose) Each dose is maintained for at least four weeks before escalation

Patients with gastrointestinal disorders, such as Crohns disease, celiac disease, or those who have undergone gastrointestinal surgeries like bariatric surgery, may also find B12 injections advantageous

4(1):e1263717

I'd love to hear about your experience in the comments below